Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
India’s indigenous COVID-19 vaccine, Covaxin, developed through collaboration between the Indian Council of Medical Research (ICMR) and Bharat Biotech International Limited (BBIL), is publicly stated to have jointly owned intellectual property rights. However, patent filings in India, the US, and Europe list only BBIL…
Share This Article
Ready-to-post copy includes the article link.
Patent Filings Attribute Covaxin Invention Solely to Bharat Biotech, Excluding ICMR Despite Government Claims India’s indigenous COVID-19 vaccine, Covaxin, developed through collaboration between the Indian Council of Medical Research (ICMR) and Bharat Biotech International Limited (BBIL), is publicly stated to have jointly own... Read the full IIPLA article: https://iipla.org/news/patent-filings-attribute-covaxin-invention-solely-to-bharat-biotech-excluding-icmr-despite-government-claims